IV
IVPR
INSPIRE VETERINARY PARTNERS, INC.
$0.002000
0.00%
No data for this timeframe.
Vol
Inst. Holders2 funds
Inst. Value$3.00
Inst. Activity1 buys / 1 sells
SEC Reports2
Recent Activity
Jun 4, 2026
SEC
Nasdaq filed Form 25-NSE to remove Inspire Veterinary Partners' Class A Common Stock from listing, effective June 15, 20
25-NSE — Impact 8/10
May 7, 2026
SEC
Inspire Veterinary Partners filed Form 15-12G to terminate its SEC registration under Section 12(g), effective May 7, 20
15-12G — Impact 7/10
Inst.
UBS Group AG — NEAR_EXIT
576 shares ($565.00)
Inst.
BANK OF AMERICA CORP — ADD
29 shares ($28.00)
Latest Reports
BEARISH
25-NSE
8/10
Nasdaq filed Form 25-NSE to remove Inspire Veterinary Partners' Class A Common Stock from listing, effective June 15, 20
Jun 4, 2026
BEARISH
15-12G
7/10
Inspire Veterinary Partners filed Form 15-12G to terminate its SEC registration under Section 12(g), effective May 7, 20
May 7, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BANK OF AMERICA CORP | $2.00 | ADD |
| WELLS FARGO & COMPANY/MN | $1.00 | DOUBLED |
2 institutional holders with $3.00 total value (47 shares) as of 2025-Q4. Top holders: BANK, WELLS.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BANK OF AMERICA CORP /DE/ | 32 | $2.00 | 66.7% | ADD +52.6% |
| 2 | WELLS FARGO & COMPANY/MN | 15 | $1.00 | 33.3% | DOUBLED +275.0% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| UBS Group AG | NEAR_EXIT | 12,150 | 576 | -95.3% | $565.00 | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | ADD | 19 | 29 | +52.6% | $28.00 | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | ADD | 11 | 19 | +72.7% | $32.00 | 2025-Q2 |
| WELLS FARGO & COMPANY/MN | DOUBLED | 4 | 15 | +275.0% | $25.00 | 2025-Q2 |
| UBS Group AG | NEW | — | 11,950 | — | $20.4K | 2025-Q1 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
2 SEC filing reports analyzed. Sentiment: 0 bullish, 2 bearish, 0 mixed, 0 neutral. Avg impact: 7.5/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.